Literature DB >> 21069

Antipsychotic drugs: clinical pharmacology and therapeutic use.

J M Davis, R Casper.   

Abstract

Mesh：

Substances：

Year:  1977        PMID： 21069     DOI： 10.2165/00003495-197714040-00002

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  66 in total

1.  CHANGES IN SCHIZOPHRENIC PSYCHOPATHOLOGY AND WARD BEHAVIOUR AS A FUNCTION OF PHENOTHIAZINE TREATMENT.

Authors:  S C GOLDBERG; G L KLERMAN; J O COLE
Journal:  Br J Psychiatry       Date:  1965-02       Impact factor: 9.319

2.  A study of phenothiazines with male and female chronically ill schizophrenic patients.

Authors:  D ADELSON; L J EPSTEIN
Journal:  J Nerv Ment Dis       Date:  1962-06       Impact factor: 2.254

3.  A comparison of thioridazine, trifluoperazine, chlorpromazine, and placebo: a double-blind controlled study on the treatment of chronic, hospitalized, schizophrenic patients.

Authors:  B C SCHIELE; N D VESTRE; K E STEIN
Journal:  J Clin Exp Psychopathol Q Rev Psychiatry Neurol       Date:  1961 Jul-Sep

4.  Evaluation of loxapine succinate in chronic schizophrenia.

Authors:  M L Clark; W K Huber; J Sullivan; F Wood; J P Costiloe
Journal:  Dis Nerv Syst       Date:  1972-12

5.  Plasma disappearance and cerebral effects of chlorpromazine in cirrhosis.

Authors:  J D Maxwell; M Carrella; J D Parkes; R Williams; G P Mould; S H Curry
Journal:  Clin Sci       Date:  1972-08       Impact factor: 6.124

6.  Loxapine in newly admitted chronic schizophrenic patients.

Authors:  M L Clark; A Paredes; J P Costiloe; F Wood; A Barrett
Journal:  J Clin Pharmacol       Date:  1975-04       Impact factor: 3.126

7.  Loxapine succinate: a controlled double-blind study in chronic schizophrenia.

Authors:  B C Schiele
Journal:  Dis Nerv Syst       Date:  1975-07

8.  A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.

Authors:  B Shopsin; E Pearson; S Gershon; P Collins
Journal:  Curr Ther Res Clin Exp       Date:  1972-11

9.  Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.

Authors:  T M Itil; N Polvan; A Ucok; E Eper; F Güven; W Hsu
Journal:  Behav Neuropsychiatry       Date:  1971 Aug-Sep

10.  Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.

Authors:  S R Hirsch; R Gaind; P D Rohde; B C Stevens; J K Wing
Journal:  Br Med J       Date:  1973-03-17
View more
  17 in total

1.  Reducing the number of anticonvulsant drugs taken by severely retarded epileptic patients.

Authors:  W J Craymer; E M Crawford; C W Gowdey
Journal:  Can Fam Physician       Date:  1984-04       Impact factor: 3.275

Review 2.  Depot fluspirilene for schizophrenia.

Authors:  A Abhijnhan; C E Adams; A David; M Ozbilen
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

3.  Psychotherapeutic drugs: important adverse reactions and interactions.

Authors:  G D Burrows; T R Norman
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

Review 4.  WITHDRAWN: Risperidone versus other atypical antipsychotic medication for schizophrenia.

Authors:  Simon Gilbody; Anne-Marie Bagnall; Lorna Duggan; Arja Tuunainen
Journal:  Cochrane Database Syst Rev       Date:  2016-09-20

Review 5.  Effect of second-generation antipsychotics on cognition: current issues and future challenges.

Authors:  S Kristian Hill; Jeffrey R Bishop; Donna Palumbo; John A Sweeney
Journal:  Expert Rev Neurother       Date:  2010-01       Impact factor: 4.618

Review 6.  Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia.

Authors:  Christopher Jones; David Hacker; Irene Cormac; Alan Meaden; Claire B Irving
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

Review 7.  Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Authors:  A Fitton; R C Heel
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

Review 8.  Aripiprazole versus typical antipsychotic drugs for schizophrenia.

Authors:  Jayanti Bhattacharjee; Hany George G El-Sayeh
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

9.  Chronic molindone treatment: relative inability to elicit dopamine receptor supersensitivity in rats.

Authors:  E Meller
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 10.  Drug repurposing for the treatment of staphylococcal infections.

Authors:  Shankar Thangamani; Haroon Mohammad; Waleed Younis; Mohamed N Seleem
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.